Robotics TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided Surgery byChris StewartFebruary 23, 2021
Financial TransEnterix Announces Closing of $79.6 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares byChris StewartFebruary 1, 2021
Financial TransEnterix Announces $31.25 Million Registered Direct Offering of Common Stock byChris StewartJanuary 12, 2021
Financial Robotics TransEnterix Provides Preliminary 2020 Year-End Corporate Update byJosh SandbergJanuary 6, 2021
Regulatory Robotics TransEnterix Announces Approval of Senhance® Surgical System in Russian Federation byChris StewartDecember 16, 2020
Financial TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2020 byChris StewartNovember 5, 2020
Financial TransEnterix, Inc. Reports Operating and Financial Results for the Second Quarter 2020 byJosh SandbergAugust 5, 2020
Financial TransEnterix Announces Pricing of $13.0 Million Underwritten Public Offering of Common Stock byJosh SandbergJuly 1, 2020
Hospitals Robotics TransEnterix Announces Sana Klinikum Offenbach to Initiate Program with the Senhance Surgical System byJosh SandbergJune 23, 2020
